Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
Titel:
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
Auteur:
Dal Pra, A. Ghadjar, P. Ryu, H.M. Proudfoot, J.A. Hayoz, S. Michalski, J.M. Spratt, D.E. Liu, Y. Schär, C. Berlin, A.M. Zwahlen, D.R. Simko, J.P. Hölscher, T. Efstathiou, J.A. Polat, B. Sandler, H.M. Hildebrandt, G. Parliament, M.B. Mueller, A.-C. Dayes, I.S. Plasswilm, L. Correa, R.J.M. Robertson, J.M. Karrison, T.G. Davicioni, E. Hall, W.A. Feng, F.Y. Pollack, A. Thalmann, G.N. Nguyen, P.L. Aebersold, D.M. Tran, P.T. Zhao, S.G.